Moneycontrol PRO
HomeNewsViolet arch capital

Violet Arch Capital

Jump to
  • Nifty has strong resistance between 8390-8434: Violet Arch

    In an interview to CNBC-TV18, Mithil Pradhan of Violet Arch Capital Advisors shares his views on the current market and key Nifty levels to be watched out for right now.

  • Capital goods expensive now, rally on poll hopes: Experts

    Capital goods expensive now, rally on poll hopes: Experts

    Sanju Verma, Group CEO, Violet Arch Capital, says Order book to sales for most capital goods companies has always been pretty healthy, anywhere between 2.5-3 times revenues. But the working capital cycle is still under tremendous strain

  • Bullish on Hindalco, keep JSPL in portfolio: Sanju Verma

    Bullish on Hindalco, keep JSPL in portfolio: Sanju Verma

    Sanju Verma, Group CEO of Violet Arch Capital is bullish on Hindalco Industries due to Novelis performance. She recommends keeping Jindal Steel & Power in the portfolio.

  • Sanju Verma bullish on Tech Mahindra

    Sanju Verma bullish on Tech Mahindra

    Sanju Verma, Group CEO of Violet Arch Capital is bullish on Tech Mahindra. "For the last six quarters, it has shown a CQGR revenue growth in dollar terms of 4.6 percent which is excellent even in the September quarter," she reasoned.

  • Cautious on capital goods, Voltas looks expensive: Verma

    Cautious on capital goods, Voltas looks expensive: Verma

    Sanju Verma, Group CEO of Violet Arch Capital is cautious on capital goods space. She feels Voltas looks like an expensive stock at the current price.

  • Britannia Industries may head towards Rs 1050: Sanju Verma

    Britannia Industries may head towards Rs 1050: Sanju Verma

    Sanju Verma, Group CEO of Violet Arch Capital is of the view that Britannia Industries may move all the way to Rs 1050.

  • Buy Power Grid December Put option: Sanju Verma

    Buy Power Grid December Put option: Sanju Verma

    Sanju Verma, Group CEO of Violet Arch Capital is of the view that one may buy Power Grid Corporation of India December Put Option or avoid follow-on public offer.

  • Continue buying pharma; bullish on HCL Tech: Sanju Verma

    Continue buying pharma; bullish on HCL Tech: Sanju Verma

    Sanju Verma continues to be disappointed with Infosys despite its 4 percent volume growth sequentially. “At this point the one company that we continue to like is HCL Tech. I also like Tata Consultancy Services (TCS),” she adds.

  • Sensex may see 22000 by March 2013: Sanju Verma

    Sensex may see 22000 by March 2013: Sanju Verma

    Sanju Verma, managing director and chief executive officer of Violet Arch Capital says that the market will move from strength to strength before even coming anywhere close to overvalued zone.

  • Sanju Verma backs PSU banks despite sub-par Q2 performance

    Sanju Verma backs PSU banks despite sub-par Q2 performance

    In an interview to CNBC-TV18, Sanju Verma, MD & CEO, Violet Arch Capital Advisors spoke about the PSUs specifically, SBI which is releasing its results today. Verma tell us why inspite of PSUs not doing well he will still bet on SBI.

  • Sell BHEL on rally, says Mithil Pradhan

    Sell BHEL on rally, says Mithil Pradhan

    Sell BHEL on rally, says Mithil Pradhan, Violet Arch Capital.

  • Significant reforms from current govt unlikely: Sanju Verma

    Significant reforms from current govt unlikely: Sanju Verma

    Sanju Verma of Violet Arch Capital tells CNBC-TV18 that she isn‘t holding high hopes for significant reforms from the current government.

  • Tata Motors may slip to Rs 160- 168, says Pradhan

    Tata Motors may slip to Rs 160- 168, says Pradhan

    Tata Motors may slip to Rs 160- 168, says Mithil Pradhan, Violet Arch Capital.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347